Ly93
Ly93 is a selective and orally active sphingomyelin synthase 2 (SMS2) inhibitor, with an IC50 of 91 nM[1].
Product Specifications
CAS Number
[1883528-69-5]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Phospholipase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ly93.html
Purity
99.85
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=CN=C1)C2=CC=CC=C2OCC3=C(CC)C=CC=C3
Molecular Formula
C21H20N2O2
Molecular Weight
332.40
Precautions
H315, H319, H335
References & Citations
[1]Li Y, et al. Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor. Eur J Med Chem. 2019 Feb 1;163:864-882.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15155727 1 Vial
Lentiviral human NAGA shRNA (UAS) - Lentiviral human NAGA shRNA (UAS, iRFP) (100)
Ask
View Details RR205634L4V 200 µL
LOC498971 (NM_001047936) Rat Tagged ORF Clone Lentiviral Particle
Ask
View Details